Skip to main content
Back to Trials
NCT07777744Recruiting

Severe Complications During Ventricular Tachycardia or Premature Ventricular Complex Ablation

University Hospital, Basel, Switzerland

Start Date

7/1/2024

Completion Date

12/31/2028

Summary

The investigators aim to characterize patients presenting with a severe ventricular tachycardia (VT) and premature ventricular complex (PVC)-ablation-related complication including patient characteristics, procedural details and subsequent management of the complication by gathering existing patient-level data.

Eligibility Criteria

Age Range: 18 years to No maximum

Inclusion Criteria: * Centers : Centers participating in the present collaborative study group. Invitation to participate will be based either upon personal referral of one of the investigator, previous collaboration or based on a meta-analytic review of the literature published on the subject within the past 20 years. * Patients: Females and males of \>18 years undergoing any type of VT/PVC ablation. While we will accept redo-procedure we will ask for a unique patient-identifier to link procedures belonging to the same patients together. * Interventions: VT/PVC ablation (first intervention or re-do) as routinely performed by the participating centers * Outcomes: Severe complications, defined as hemodynamic instability requiring mechanical intensive-care management, tamponade, stroke, cardiac arrest, myocardial infarction, phrenic nerve palsies, major bleeding requiring transfusion, vascular or cardiac complication requiring surgery, procedure-related death. * Setting: Observational cohort studies, registries, retrospective cohort studies. Data stemming from RCTs (Randomized controlled trials) will not be collected as they likely do not represent a "real-life" setting. * Length of follow-up: Peri-procedural complications * Years considered: Not limited to a specific time-frame, but to reflect common ablation practices, we will focus on data from the 20 past years. * Number of patients provided : No lower limit of patients provided per dataset or ablation volume per year to include high- as well as low-volume centers Exclusion Criteria: * Refusal of the center to participate. * Less than 10 procedures available in the dataset (no case reports) * Missing essential baseline characteristics, missing collection of sufficient details regarding each complication.

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Ventricular Tachycardia (VT)Premature Ventricular Complexes

Locations

Rush University Medical Center

Chicago, Illinois 60612

United States

University of Michigan

Michigan Center, Michigan 48109

United States

Medical University of Graz

Graz,

Austria

Université Laval

Québec,

Canada

The First Affiliated Hospital of Nanjing Medical University

Nanjing,

China

University Hospital Center Sestre milosrdnice

Zagreb,

Croatia

CHU Bordeaux

Bordeaux,

France

Centre Hospitalier Universitaire Trousseau

Chambray-lès-Tours,

France

University Hospital Poitier

Poitiers,

France

Clinique Pasteur Toulouse

Toulouse,

France

Zentralklinik Bad Bercka

Bad Berka,

Germany

Uniklinik Freiburg

Bad Krozingen,

Germany

Carl-Thiem-Klinikum

Cottbus,

Germany

Universitätsklinikum Münster

Münster,

Germany

University of Patras

Pátrai,

Greece

Sheba Medical Center

Ramat Gan,

Israel

Citta della Salute e della Scienza di Torino

Torino,

Italy

Mount Elisabeth Medical Centre

Singapore,

Singapore

University Medical Center Ljubljana

Ljubljana,

Slovenia

Hospital Universitario Ramón y Cajal

Madrid,

Spain

University Hospital Basel

Basel, 4031

Switzerland

Inselspital Bern

Bern,

Switzerland

Ankara City Hospital

Ankara,

Turkey (Türkiye)

Hacettepe University

Ankara,

Turkey (Türkiye)

Royal Papworth Hospital

Cambridge,

United Kingdom